Human neuroblastoma cells exposed to hypoxia: Induction of genes associated with growth, survival, and aggressive behavior

Experimental Cell Research

Volumn 295, Issue 2, 2004, Pages 469-487

  Jögi, Annika ^a   Vallon Christersson, Johan ^a   Holmquist, Linda ^a   Axelson, Håkan ^a   Borg, Åke ^a   Påhlman, Sven ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Dedifferentiation; Differentiation; Hypoxia; Microarray; Neuroblastoma; Survival; Tumor

Indexed keywords

ADRENOMEDULLIN; GLUCOSE; INHIBITOR OF DIFFERENTIATION 2; IRON; METALLOTHIONEIN; MULTIDRUG RESISTANCE PROTEIN 1; NEUROPILIN 1; SECRETOGRANIN II; SECRETONEURIN; SOMATOMEDIN B; TRANSCRIPTION FACTOR; VASCULOTROPIN;

AGGRESSION; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL HYPOXIA; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE INDUCTION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IRON METABOLISM; MOLECULAR MECHANICS; NERVE CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL; UPREGULATION;

EID: 1842861743     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.01.013     Document Type: Article

References (89)

1. Brown J.M. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today. 6:2000;157-162.
2. Vaupel P., Thews O., Hoeckel M. Treatment resistance of solid tumors. Med. Oncol. 18:2001;243-259.
3. Brizel D.M., Scully S.P., Harrelson J.M., Layfield L.J., Bean J.M., Prosnitz L.R., Dewhirst M.W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
4. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835.
5. Reynolds T.Y., Rockwell S., Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56:1996;5754-5757.
6. Jögi A., Øra I., Nilsson H., Lindeheim A., Makino Y., Poellinger L., Axelson H., Påhlman S. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7021-7026.
7. Hedborg F., Bjelfman C., Sparen P., Sandstedt B., Påhlman S. Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome. Eur. J. Cancer. 4:1995;435-443.
8. Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castelberry R.P., De Bernardi B., Evans A.E., Favrot M., Hedborg F.et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 11:1993;1466-1477.
9. Bjelfman C., Hedborg F., Johansson I., Nordenskjöld M., Påhlman S. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis. Cancer Res. 50:1990;6908-6914.
10. Helczynska K., Kronblad A., Jögi A., Nilsson E., Beckman S., Landberg G., Påhlman S. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 63:2003;1441-1444.
11. Hoehner J.C., Gestblom C., Hedborg F., Sandstedt B., Olsen L., Påhlman S. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab. Invest. 75:1996;659-675.
12. Gestblom C., Hoehner J.C., Hedborg F., Sandstedt B., Påhlman S. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas. Am. J. Pathol. 150:1997;107-117.
13. Påhlman S., Hedborg F. Development of the neural crest and sympathetic nervous system. Brodeur G.M., Sawada T., Tsuchida Y., Voute P.A. Neuroblastoma. 2000;Elsevier, Amsterdam.
14. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A. 92:1995;5510-5514.
15. Tian H., Hammer R.E., Matsumoto A.M., Russell D.W., McKnight S.L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12:1998;3320-3324.
16. Wiesener M.S., Turley H., Allen W.E., Willam C., Eckardt K.U., Talks K.L., Wood S.M., Gatter K.C., Harris A.L., Pugh C.W., Ratcliffe P.J., Maxwell P.H. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood. 92:1998;2260-2268.
17. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4273-4278.
18. Ema M., Hirota K., Mimura J., Abe H., Yodoi J., Sogawa K., Poellinger L., Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18:1999;1905-1914.
19. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E., Keshet E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490.
20. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., Gassmann M., Gearhart J.D., Lawler A.M., Yu A.Y., Semenza G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12:1998;149-162.
21. Morrison S.J., Csete M., Groves A.K., Melega W., Wold B., Anderson D.J. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J. Neurosci. 20:2000;7370-7376.
22. Yun Z., Maecker H.L., Johnson R.S., Giaccia A.J. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev. Cell Biol. 2:2002;331-341.
23. Saal L.H., Troein J., Vallon-Christersson J., Gruvberger S., Borg Å., Peterson C. BioArray software environment: a platform for comprehensive management and analysis of microarray data. Genome Biol. 3:2002;1-6. (SOFTWARE0003).
24. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., Speed T.P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 15:2002;e15.
25. Vandesompele J., De Paepe A., Speleman F. Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal. Biochem. 303:2002;95-98.
26. De Preter K., Speleman F., Combaret V., Lunec J., Laureys G., Eussen B.H., Francotte N., Board J., Pearson A.D., De Paepe A., Van Roy N., Vandesompele J. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod. Path. 15:2002;159-166.
27. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:2002;1-12. (RESEARCH0034).
28. Persson P., Jögi A., Grynfeld A., Påhlman S., Axelson H. HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. Biochem. Biophys. Res. Commun. 274:2000;22-31.
29. Tweddle D.A., Malcolm A.J., Bown N., Pearson A.D., Lunec J. Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res. 61:2001;8-13.
30. Keshelava N., Zuo J.J., Chen P., Waidyaratne S.N., Luna M.C., Gomer C.J., Triche T.J., Reynolds C.P. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res. 61:2001;6185-6193.
31. Harris A.L. Hypoxia - A key regulatory factor in tumour growth. Nat. Rev., Cancer. 2:2002;38-47.
32. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:1994;23757-23763.
33. Loncaster J.A., Harris A.L., Davidson S.E., Logue J.P., Hunter R.D., Wycoff C.C., Pastorek J., Ratcliffe P.J., Stratford I.J., West C.M. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61:2001;6394-6399.
34. Zhang K., Lindsberg P.J., Tatlisumak T., Kaste M., Olsen H.S., Andersson L.C. Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3637-3642.
35. Park H., Adams M.A., Lachat P., Bosman F., Pang S.C., Graham C.H. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem. Biophys. Res. Commun. 276:2000;321-328.
36. Shimono A., Okuda T., Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech. Dev. 83:1999;39-52.
37. Tanimoto K., Makino Y., Pereira T., Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von hippel-lindau tumor suppressor protein. EMBO J. 19:2000;4298-4309.
38. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:1999;6519-6525.
39. Mundel P., Heid H.W., Mundel T.M., Kruger M., Reiser J., Kriz W. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J. Cell Biol. 139:1997;193-204.
40. Lin F., Yu Y.P., Woods J., Cieply K., Gooding B., Finkelstein P., Dhir R., Krill D., Becich M.J., Michalopoulos G., Finkelstein S., Luo J.H. Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers. Am. J. Pathol. 159:2001;1603-1612.
41. Massari M.E., Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20:2000;429-440.
42. Johnson J.E., Birren S.J., Saito T., Anderson D.J. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3596-3600.
43. Firulli B.A., Hadzic D.B., McDaid J.R., Firulli A.B. The basic helix-loop-helix transcription factors dHAND and eHAND exhibit dimerization characteristics that suggest complex regulation of function. [In Process Citation] J. Biol. Chem. 275:2000;33567-33573.
44. Jögi A., Persson P., Grynfeld A., Påhlman S., Axelson H. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J. Biol. Chem. 277:2002;9118-9126.
45. Cooper M.J., Hutchins G.M., Cohen P.S., Helman L.J., Mennie R.J., Israel M.A. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ. 1:1990;149-159.
46. Van Limpt V.A., Chan A.J., Van Sluis P.G., Caron H.N., Van Noesel C.J., Versteeg R. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int. J. Cancer. 105:2003;61-69.
47. Mattsson M.E., Enberg G., Ruusala A.I., Hall K., Påhlman S. Mitogenic response of human SH-SY5Y neuroblastoma cells to insulin-like growth factor I and II is dependent on the stage of differentiation. J. Cell Biol. 102:1986;1949-1954.
48. Mattsson M.E., Hammerling U., Mohall E., Hall K., Påhlman S. Mitogenically uncoupled insulin and IGF-I receptors of differentiated human neuroblastoma cells are functional and mediate ligand-induced signals. Growth Factors. 2:1990;251-265.
49. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
50. Zudaire E., Martinez A., Cuttitta F. Adrenomedullin and cancer. Regul. Pept. 112:2003;175-183.
51. Jin R., Chow V.T., Tan P.H., Dheen S.T., Duan W., Bay B.H. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis. 23:2002;81-86.
52. Doz F., Roosen N., Rosenblum M.L. Metallothionein and anticancer agents: the role of metallothionein in cancer chemotherapy. J. Neurooncol. 17:1993;123-129.
53. He T., Wei D., Fabris D., Fenselau C. Intracellular sequestration of anti-tumor drugs by metallothionein. Cell. Mol. Biol. (Noisy-le-grand). 46:2000;383-392.
54. Endresen L., Rugstad H.E. Protective function of metallothionein against certain anticancer agents. Experientia, Suppl. 52:1987;595-602.
55. Ebadi M., Iversen P.L. Metallothionein in carcinogenesis and cancer chemotherapy. Gen. Pharmacol. 25:1994;1297-1310.
56. Kelley S.L., Basu A., Teicher B.A., Hacker M.P., Hamer D.H., Lazo J.S. Overexpression of metallothionein confers resistance to anticancer drugs. Science. 241:1988;1813-1815.
57. Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalso M.C., Colgan S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62:2002;3387-3394.
58. Ghafar M.A., Anastasiadis A.G., Chen M.W., Burchardt M., Olsson L.E., Xie H., Benson M.C., Buttyan R. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate. 54:2003;58-67.
59. Park S.K., Dadak A.M., Haase V.H., Fontana L., Giaccia A.J., Johnson R.S. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol. Cell. Biol. 23:2003;4959-4971.
60. Hoehner J.C., Gestblom C., Olsen L., Påhlman S. Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma. Br. J. Cancer. 75:1997;1185-1194.
61. Berthold F., Schilling F., Harms D., Sandstedt B., Franklin G. Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma. FASEB J. 17:2003;598-609.
62. Kähler C.M., Schratzberger P., Wiedermann C.J. Response of vascular smooth muscle cells to the neuropeptide secretoneurin. Arterioscler., Thromb., Vasc. Biol. 17:1997;2029-2035.
63. Baek J.H., Jang J.E., Kang C.M., Chung H.Y., Kim N.D., Kim K.W. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene. 19:2000;4621-4631.
64. Rössler J., Schwab M., Havers W., Schweigerer L. Hypoxia promotes apoptosis of human neuroblastoma cell lines with enhanced N-myc expression. Biochem. Biophys. Res. Commun. 281:2001;272-276.
65. Bachelder R.E., Crago A., Chung J., Wendt M.A., Shaw L.M., Robinson G., Mercurio A.M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res. 61:2001;5736-5740.
66. Bachelder R.E., Lippscomb E.A., Lin X., Wendt M.A., Chadborn N.H., Eickholt B.J., Mercurio A.M. Competing autocrine pathways involving alternative Neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 63:2003;5230-5233.
67. Lavenius E., Parrow V., Nånberg E., Påhlman S. Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture. Growth Factors. 10:1994;29-39.
68. Påhlman S., Meyerson G., Lindgren E., Schalling M., Johansson I. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. U. S. A. 88:1991;9994-9998.
69. van Golen C.M., Castle V.P., Feldman E.L. IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma. Cell Death Differ. 7:2000;654-665.
70. Dutta R., Sens D.A., Somji S., Sens M.A., Garrett S.H. Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells. Prostate. 52:2002;89-97.
71. Volm M., Koomagi R., Mattern J., Efferth T. Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br. J. Cancer. 87:2002;251-257.
72. Koomagi R., Mattern J., Volm M. Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis. 16:1995;2129-2133.
73. Mattern J., Kallinowski F., Herfarth C., Volm M. Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int. J. Cancer. 67:1996;20-23.
74. Vannucci S.J., Reinhart R., Maher F., Bondy C.A., Lee W.H., Vannucci R.C., Simpson I.A. Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Brain Res., Dev. Brain Res. 107:1998;255-264.
75. Szturmowicz M., Burakowski J., Tomkowski W., Sakowicz A., Filipecki S. Neuron-specific enolase in non-neoplastic lung diseases, a marker of hypoxemia? Int. J. Biol. Markers. 13:1998;150-153.
76. Riddle S.R., Ahmad A., Ahmad S., Deeb S.S., Malkki M., Schneider B.K., Allen C.B., White C.W. Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am. J. Physiol., Lung Cell. Mol. Physiol. 278:2000;L407-L416.
77. Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood. 99:2002;3505-3516.
78. Lee P.J., Jiang B.H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., Choi A.M. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272:1997;5375-5381.
79. Czyzyk-Krzeska M.F., Furnari B.A., Lawson E.E., Millhorn D.E. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J. Biol. Chem. 269:1994;760-764.
80. Cormier-Regard S., Nguyen S.V., Claycomb W.C. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273:1998;17787-17792.
81. Udono T., Takahashi K., Nakayama M., Yoshinoya A., Totsune K., Murakami O., Durlu Y.K., Tamai M., Shibahara S. Induction of adrenomedullin by hypoxia in cultured retinal pigment epithelial cells. Invest. Ophthalmol. Visual Sci. 42:2001;1080-1086.
82. Jiang B.H., Rue E., Wang G.L., Roe R., Semenza G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271:1996;17771-17778.
83. Flamme I., Krieg M., Plate K.H. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha. Am. J. Pathol. 153:1998;25-29.
84. Bae S.K., Bae M.H., Ahn M.Y., Son M.J., Lee Y.M., Bae M.K., Lee O.H., Park B.C., Kim K.W. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 59:1999;5989-5994.
85. Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., Semenza G. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 59:1999;3915-3918.
86. Lal A., Peters H., St Croix B., Haroon Z.A., Dewhirst M.W., Strausberg R.L., Kaanders J.H., van der Kogel A.J., Riggins G.J. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst. 93:2001;1337-1343.
87. Sriuranpong V., Borges M.W., Strock C.L., Nakakura E.K., Watkins D.N., Blaumueller C.M., Nelkin B.D., Ball D.W. Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol. Cell. Biol. 22:2002;3129-3139.
88. Chen H., Thiagalingam A., Chopra H., Borges M.W., Feder J.N., Nelkin B.D., Baylin S.B., Ball D.W. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5355-5360.
89. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:1990;49-59.